Low nuclear and cytoplasmic expression of Cdk5 is associated with poor breast cancer‐specific survival of breast cancer patients; in addition to survival, Cdk5 expression was associated with a number of clinicopathological criteria indicative of poor prognosis. This evidence concerns the gene CDK5 and breast carcinoma.